Mylan Investors Get Cert. In EpiPen Securities Fraud Action
A New York federal judge granted certification Monday to a class of thousands of Mylan NV investors who say the pharmaceutical giant committed securities fraud by misleading them about how it...To view the full article, register now.
Already a subscriber? Click here to view full article